TP53 and urothelial carcinoma: With an optimal cutoff of 5%, p53 immunostaining was a significant method for identifying urinary cancer with cytological atypia that cannot exclude Low-grade urothelial carcinoma, suspicious for high-grade urothelial carcinoma, and High-grade urothelial carcinoma.